In a report released on January 27, Manjari Dhar from RBC Capital maintained a Buy rating on Hugo Boss (0Q8F – Research Report), with a price ...

The Women Presidents’ Organization (WPO), a global peer advisory organization for women entrepreneurs leading ...

On the geopolitical front, Dimon said the bank continues to face uncertainty as wars rage in Ukraine and the Middle East, and new governments could be taking over in France, Germany and Canada. Other ...

Solomon Moshkevich, Natera's president of clinical diagnostics, said that the firm has seen strong growth in MRD testing in 2023 and 2024 that has been driven by both new physician users and existing ...

JPMorgan Chase & Co.'s Chief Executive Jamie Dimon said the U.S. economy remains "resilient" but he remains wary of inflation ...

The bank said profit rose 50% to $14 billion in the fourth quarter as noninterest expenses fell 7% from a year earlier.

Big bank profits surged in the fourth quarter and Wall Street roared back to life, with net income rising 50% at JPMorgan ...

JPMorgan CEO Jamie Dimon addressed his retirement timeline, Goldman chief David Solomon talked Apple, and bankers overall ...

JPMorgan Chase & Co.’s traders scored their biggest fourth-quarter haul ever, boosted by volatility tied to the U.S. elections in November. Trading revenue at the firm rose 21% from a year earlier, ...

The $4 trillion-asset bank posted its highest-ever annual profit but also said its CEO succession plan is still in the works.

Denali Therapeutics showcases its BBB platform at J.P. Morgan Conference, highlighting DNL310's Hunter syndrome progress and plans for commercialization.

Despite Leqembi's initial slow sales, the firm's CEO cited areas for the drug's growth and ambitions for an antisense ...